Moleculin Biotech, Inc. Current Assets
Moleculin Biotech, Inc. (MBRX) had Current Assets of $8.72 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $8.72M.
- 2026-03-31: Assets, Current $10.96M.
- 2025-12-31: Assets, Current $9.69M.
- 2025-09-30: Assets, Current $7.88M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.72M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $10.96M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $9.69M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $7.88M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $9.08M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $9.34M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $5.19M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $11.61M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $13.73M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $18.96M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $26.27M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $27.60M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $35.38M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $39.29M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $45.60M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $53.49M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $61.32M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $67.26M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $72.50M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $77.07M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $81.84M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $88.02M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $17.20M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $15.25M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $19.75M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $13.79M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $13.48M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $18.59M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $20.20M 10-Q · filed 2019-08-16 | |
| 2019-03-31 | $9.61M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $7.97M 10-K · filed 2020-03-19 | |
| 2018-09-30 | $9.36M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $12.89M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $13.75M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $8.30M 10-K · filed 2019-02-21 | |
| 2017-09-30 | $9.46M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $10.08M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $9.15M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $5.22M 10-K · filed 2018-03-28 | $5.22M 10-K · filed 2017-04-03 |
| 2016-09-30 | $6.43M 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $7.56M 10-Q · filed 2016-11-21 | |
| 2015-12-31 | $28.09K 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |